VR1 12.5% 0.9¢ vection technologies ltd

General Company Chat, page-38

  1. 1,645 Posts.
    lightbulb Created with Sketch. 282
    Hi Sepfit, no idea unfortunately. I see the patent as a bonus here, as the success, or not, of the hospital trial and subsequent adoption of the AR applications will not hinge on the patent being granted. Clearly, however, the business needs to protect its IP and would be wanting the patent to be granted quickly. Others may well have a better, more informed idea.
    Last edited by davroz1865: 30/09/20
 
watchlist Created with Sketch. Add VR1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.